The Association between Human Epididymis Secretory Protein 4 and Metabolic Syndrome

Area of Science:

• Biomedical Research
• Oncology
• Endocrinology

Background:

• Metabolic syndrome (MetS) increases cancer risk.
• Human epididymis protein 4 (HE4) is an established tumor marker for epithelial ovarian carcinoma (EOC).
• The relationship between MetS and HE4 levels remains unexplored.

Purpose of the Study:

• To investigate the association between metabolic syndrome (MetS) and serum HE4 levels.
• To determine if MetS components correlate with HE4 levels in adult females.

Main Methods:

• Cross-sectional analysis of 2104 adult females from the NHANES 2001-2002 dataset.
• Metabolic syndrome (MetS) defined by NCEP ATPIII criteria, assessing all five components.
• Statistical analysis using regression models to evaluate HE4 levels in relation to MetS presence and component count.

Main Results:

• A significant association was found between the presence of MetS and elevated HE4 levels (β = 0.097, p = 0.006).
• HE4 levels showed a positive trend with an increasing number of MetS components (p < 0.001).
• Low high-density lipoprotein and high triglyceride levels were independently associated with higher HE4 levels.

Conclusions:

• Metabolic syndrome (MetS) is significantly associated with elevated Human epididymis protein 4 (HE4) levels.
• The degree of association between MetS and HE4 increases with the number of MetS components.
• Specific MetS components, namely low HDL and high triglycerides, are independently linked to higher HE4 levels, suggesting potential roles in carcinogenesis.